Resistance mechanisms of EGFR tyrosine kinase inhibitors, in EGFR exon 20 insertion-mutant lung cancer
European Journal of Cancer · 2024-09 · 208 · 114206
DOI: 10.1016/j.ejca.2024.114206 ↗Kurz gefasst
Fachartikel in der Zeitschrift European Journal of Cancer, 2024-09. Verfasst von Siyeon Park und 15 weiteren Autor:innen. Beteiligte Einrichtung: Seoul National University Cancer Research Institute, Seoul, South Korea. Hauptthemen laut MEDLINE: Carcinoma, Non-Small-Cell Lung, Drug Resistance, Neoplasm, ErbB Receptors, Exons. Die Arbeit wurde bisher 13-mal zitiert (Crossref) und nennt 39 Literaturangaben. Gefördert von: National Research Foundation of Korea.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Seoul National University Cancer Research Institute, Seoul, South Korea.
- Inocras Inc., San Diego, CA, USA; Graduate School of Medical Science and Engineering, Korea Advanced Institute of Science and Technology, Daejeon, South Korea.
- Seoul National University Cancer Research Institute, Seoul, South Korea; Department of Internal Medicine, Seoul National University Hospital, Seoul, South Korea. Electronic address: gabriel9@snu.ac.kr.
- Seoul National University Cancer Research Institute, Seoul, South Korea; Integrated Major in Innovative Medical Science, Seoul National University College of Medicine, Seoul, South Korea.
- Department of Pathology, Seoul National University College of Medicine, Seoul, South Korea.
- Inocras Inc., San Diego, CA, USA.
Förderung
- National Research Foundation of Korea
Zitieren
APA
Park, S., Park, S., Kim, T. M., Kim, S., Koh, J., Lim, J., Yi, K., Yi, B., Ju, Y. S., Kim, M., Keam, B., Kim, J. S., Jeon, Y. K., Kim, D. W., Kim, Y. T., & Heo, D. S. (2024). Resistance mechanisms of EGFR tyrosine kinase inhibitors, in EGFR exon 20 insertion-mutant lung cancer. European Journal of Cancer, 208, 114206. https://doi.org/10.1016/j.ejca.2024.114206
Vancouver
Park S, Park S, Kim TM, Kim S, Koh J, Lim J, et al. Resistance mechanisms of EGFR tyrosine kinase inhibitors, in EGFR exon 20 insertion-mutant lung cancer. European Journal of Cancer. 2024;208:114206. doi:10.1016/j.ejca.2024.114206
BibTeX
@article{Park2024,
author = {Park, Siyeon and Park, Seongyeol and Kim, Tae Min and Kim, Soyeon and Koh, Jaemoon and Lim, Joonoh and Yi, Kijong and Yi, Boram and Ju, Young Seok and Kim, Miso and Keam, Bhumsuk and Kim, Jung Sun and Jeon, Yoon Kyung and Kim, Dong-Wan and Kim, Young Tae and Heo, Dae Seog},
title = {Resistance mechanisms of EGFR tyrosine kinase inhibitors, in EGFR exon 20 insertion-mutant lung cancer},
journal = {European Journal of Cancer},
year = {2024},
volume = {208},
pages = {114206},
doi = {10.1016/j.ejca.2024.114206}
}
EUVIMED